UniProt ID | BNI3L_HUMAN | |
---|---|---|
UniProt AC | O60238 | |
Protein Name | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like | |
Gene Name | BNIP3L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 219 | |
Subcellular Localization |
Nucleus envelope. Endoplasmic reticulum. Mitochondrion outer membrane. Membrane Single-pass membrane protein . Colocalizes with SPATA18 at the mitochondrion outer membrane. |
|
Protein Description | Induces apoptosis. Interacts with viral and cellular anti-apoptosis proteins. Can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. Inhibits apoptosis induced by BNIP3. Involved in mitochondrial quality control via its interaction with SPATA18/MIEAP: in response to mitochondrial damage, participates in mitochondrial protein catabolic process (also named MALM) leading to the degradation of damaged proteins inside mitochondria. The physical interaction of SPATA18/MIEAP, BNIP3 and BNIP3L/NIX at the mitochondrial outer membrane regulates the opening of a pore in the mitochondrial double membrane in order to mediate the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix. May function as a tumor suppressor.. | |
Protein Sequence | MSSHLVEPPPPLHNNNNNCEENEQSLPPPAGLNSSWVELPMNSSNGNDNGNGKNGGLEHVPSSSSIHNGDMEKILLDAQHESGQSSSRGSSHCDSPSPQEDGQIMFDVEMHTSRDHSSQSEEEVVEGEKEVEALKKSADWVSDWSSRPENIPPKEFHFRHPKRSVSLSMRKSGAMKKGGIFSAEFLKVFIPSLFLSHVLALGLGIYIGKRLSTPSASTY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | Phosphorylation | PPPAGLNSSWVELPM CCCCCCCCCEEECCC | 30.53 | - | |
35 | Phosphorylation | PPAGLNSSWVELPMN CCCCCCCCEEECCCC | 33.78 | - | |
62 | Phosphorylation | GGLEHVPSSSSIHNG CCCCCCCCCCCCCCC | 41.59 | 23401153 | |
63 | Phosphorylation | GLEHVPSSSSIHNGD CCCCCCCCCCCCCCC | 23.26 | 23401153 | |
64 | Phosphorylation | LEHVPSSSSIHNGDM CCCCCCCCCCCCCCH | 37.33 | 30266825 | |
65 | Phosphorylation | EHVPSSSSIHNGDME CCCCCCCCCCCCCHH | 29.79 | 30266825 | |
82 | Phosphorylation | LLDAQHESGQSSSRG EEEHHCCCCCCCCCC | 39.75 | 29255136 | |
85 | Phosphorylation | AQHESGQSSSRGSSH HHCCCCCCCCCCCCC | 33.53 | 29255136 | |
86 | Phosphorylation | QHESGQSSSRGSSHC HCCCCCCCCCCCCCC | 19.03 | 25849741 | |
87 | Phosphorylation | HESGQSSSRGSSHCD CCCCCCCCCCCCCCC | 46.00 | 29255136 | |
90 | Phosphorylation | GQSSSRGSSHCDSPS CCCCCCCCCCCCCCC | 18.79 | 30108239 | |
91 | Phosphorylation | QSSSRGSSHCDSPSP CCCCCCCCCCCCCCC | 30.84 | 30108239 | |
95 | Phosphorylation | RGSSHCDSPSPQEDG CCCCCCCCCCCCCCC | 32.44 | 30576142 | |
95 | Ubiquitination | RGSSHCDSPSPQEDG CCCCCCCCCCCCCCC | 32.44 | - | |
96 | Ubiquitination | GSSHCDSPSPQEDGQ CCCCCCCCCCCCCCC | 36.46 | - | |
97 | Phosphorylation | SSHCDSPSPQEDGQI CCCCCCCCCCCCCCE | 43.07 | 30576142 | |
114 | Ubiquitination | DVEMHTSRDHSSQSE EEEEECCCCCCCCCH | 46.98 | - | |
117 | Phosphorylation | MHTSRDHSSQSEEEV EECCCCCCCCCHHHH | 34.07 | 23401153 | |
118 | Phosphorylation | HTSRDHSSQSEEEVV ECCCCCCCCCHHHHH | 34.01 | 25159151 | |
120 | Phosphorylation | SRDHSSQSEEEVVEG CCCCCCCCHHHHHHC | 49.26 | 29255136 | |
129 | Ubiquitination | EEVVEGEKEVEALKK HHHHHCHHHHHHHHH | 77.30 | - | |
135 | Ubiquitination | EKEVEALKKSADWVS HHHHHHHHHHCCHHH | 52.29 | - | |
136 | Ubiquitination | KEVEALKKSADWVSD HHHHHHHHHCCHHHC | 52.29 | - | |
137 | Phosphorylation | EVEALKKSADWVSDW HHHHHHHHCCHHHCC | 29.85 | 27251275 | |
137 | Ubiquitination | EVEALKKSADWVSDW HHHHHHHHCCHHHCC | 29.85 | - | |
139 | Ubiquitination | EALKKSADWVSDWSS HHHHHHCCHHHCCCC | 54.09 | 21890473 | |
154 | Ubiquitination | RPENIPPKEFHFRHP CCCCCCCCHHCCCCC | 68.60 | 21890473 | |
154 | Ubiquitination | RPENIPPKEFHFRHP CCCCCCCCHHCCCCC | 68.60 | 21890473 | |
164 | Phosphorylation | HFRHPKRSVSLSMRK CCCCCCCCEEEEECC | 23.37 | 30266825 | |
166 | Phosphorylation | RHPKRSVSLSMRKSG CCCCCCEEEEECCCC | 18.90 | 23401153 | |
168 | Phosphorylation | PKRSVSLSMRKSGAM CCCCEEEEECCCCCC | 14.72 | 23401153 | |
176 | Acetylation | MRKSGAMKKGGIFSA ECCCCCCCCCCCCCH | 47.97 | 12431203 | |
177 | Ubiquitination | RKSGAMKKGGIFSAE CCCCCCCCCCCCCHH | 49.65 | - | |
219 | Phosphorylation | STPSASTY------- CCCCCCCC------- | 17.67 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BNI3L_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BNI3L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BNI3L_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DOK5_HUMAN | DOK5 | physical | 16189514 | |
EWS_HUMAN | EWSR1 | physical | 16189514 | |
BNI3L_HUMAN | BNIP3L | physical | 16189514 | |
TMM11_HUMAN | TMEM11 | physical | 16189514 | |
ROBO2_HUMAN | ROBO2 | physical | 21900206 | |
GNB5_HUMAN | GNB5 | physical | 21900206 | |
KLH23_HUMAN | KLHL23 | physical | 21900206 | |
GBP2_HUMAN | GBP2 | physical | 21900206 | |
MLP3A_HUMAN | MAP1LC3A | physical | 20010802 | |
BNIP3_HUMAN | BNIP3 | physical | 19060904 | |
ECM1_HUMAN | ECM1 | physical | 21988832 | |
CSKP_HUMAN | CASK | physical | 21988832 | |
KCC1D_HUMAN | CAMK1D | physical | 21988832 | |
DUS3_HUMAN | DUSP3 | physical | 21988832 | |
BNI3L_HUMAN | BNIP3L | physical | 25416956 | |
TMM11_HUMAN | TMEM11 | physical | 25416956 | |
SMCO4_HUMAN | SMCO4 | physical | 25416956 | |
CLC7A_HUMAN | CLEC7A | physical | 25416956 | |
FATE1_HUMAN | FATE1 | physical | 25416956 | |
LRAD1_HUMAN | LDLRAD1 | physical | 25416956 | |
BNIP3_HUMAN | BNIP3 | physical | 26186194 | |
BNI3L_HUMAN | BNIP3L | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120, AND MASSSPECTROMETRY. |